EdgeTestMarket TodayOptions TodayIPO
Start free

GKSLGujarat Kidney And Super Speciality Limited

Rs 177.57▲ +0.63%
Market closedEquity EOD 26 Oct
Compare
Range since listingThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.71.1% up the range
Rs 98Rs 210
GKSL price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 26 Oct
IndicatorsVolume

Loading GKSL price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 1,400 cr
Larger than 16% of 19 peers
sector middle Rs 11,802 cr
P/EPrice to earnings: how many rupees investors pay for each rupee of profit the company made over the last twelve months. Compare it with similar companies rather than reading it alone.
70.8x
Higher than 71% of 17 peers
sector middle 52.9x
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
5.5x
Lower than 56% of 18 peers
sector middle 6.0x
ROEReturn on equity: the year's profit as a percentage of the shareholders' money in the business. It shows how much the company earns on what its owners have put in.
6.6%
Lower than 82% of 17 peers
sector middle 12.1%
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
8.6%
Lower than 78% of 18 peers
sector middle 12.4%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.06
Lower than 83% of 18 peers
sector middle 0.26
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.0%
Lower than 72% of 18 peers
sector middle 0.1%

Peers are the listed companies in the exchange's own industry group: Hospital. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 14 Aug 2026), sales was Rs 34.3 cr and profit was Rs 5.3 cr.

Worth watching
  • Operations used cash in FY26 (-Rs 3.9 cr) while reported profit was Rs 16.8 cr.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Fundamentals
Trailing-twelve-month valuation, margins and growth from the company's own filings.
as of 2026-06-30
P/E (TTM)
70.8
PEG
-
EPS (TTM)
Rs 2.5
Net margin
16.6%
Rev growth YoY
-
Profit growth YoY
-
TTM revenue
Rs 101 Cr
TTM net profit
Rs 17 Cr
What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 298 Cr of assets. Its owners funded 86% of that and borrowings 5%.

What it owns
9%
34%
13%
19%
24%
Plant, property and projects27 Cr
Goodwill and intangibles102 Cr
Inventory2 Cr
Owed by customers39 Cr
Cash and bank56 Cr
Everything else72 Cr
How that is paid for
86%
Shareholders255 Cr
Borrowings16 Cr
Owed to suppliers8 Cr
Other liabilities19 Cr
Cash and equivalents
Rs 13 Cr
Net debt
Rs 2 Cr
Current ratio
3.76x
short-term assets per rupee due soon
Book value / share
Rs 32
Return on assets
5.6%
EV / EBITDA
50.4x

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs -4 Cr, spent Rs 11 Cr on plant and equipment, and cash rose by Rs 11 Cr over the year.

From running the business
-4 Cr
Spent on or received from investing
-214 Cr
From or to lenders and shareholders
+228 Cr
Net change in cash
+11 Cr

Full financial year to 2026-03-31, from the company's cash flow statement.

Against its sector
Where this stock sits within its own sector on each measure. The marker is its position in the peer group and the notch is the sector median. A position is a fact about the cohort, not a view on the stock.
Hospital · 28
P/E70.75vs 52.93 median
Cheapest: JLHL 8.84Priciest: LOTUSEYE 1419.5
Net margin16.56%vs 9.61% median
Lowest: LOTUSEYE 0.26%Highest: MAXHEALTH 16.73%
Compared against
AATMAJABHAGARWALEYEAPOLLOHOSPARTEMISMEDASTERDMDRAGARWQFORTISGPTHEALTHHCGINDRAMEDCOJLHLKIMSKMCSHILLOTUSEYEMAITREYAMANIPALHOSMAXHEALTHMEDANTAMOMSBELIEFNEPHROCARENHPARKHOSPSRAINBOWSANGANISHALBYUNIHEALTHYATHARTH

Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.

Peers side by side
Every company in the same NSE industry group that we hold figures for, largest first. Tap any heading to sort by it. The same figures as the At a glance tiles, worked out the same way for every company.
Hospital · 20 shown
Company
APOLLOHOSP
Apollo Hospitals Enterprise Limited
1.13 L cr54.0x11.9x21.8%19.5%0.578.2%+20.6%0.26%
MAXHEALTH
Max Healthcare Institute Limited
81,266 cr56.0x7.6x13.6%12.7%0.3216.7%+16.7%0.18%
MANIPALHOS
Manipal Health Enterprises Limited
73,581 cr--------
FORTIS
Fortis Healthcare Limited
55,467 cr52.9x5.6x10.5%12.0%0.2811.3%+17.5%0.14%
NH
Narayana Hrudayalaya Ltd.
33,971 cr41.4x7.5x18.0%11.4%1.079.0%+78.0%0.27%
ASTERDM
Aster DM Quality Care Limited
33,523 cr104.9x7.3x7.5%10.2%0.157.4%+21.6%0.16%
MEDANTA
Global Health Limited
32,575 cr58.6x8.2x13.9%15.1%0.3011.8%+26.5%0.04%
KIMS
Krishna Institute of Medical Sciences Limited
28,123 cr131.3x12.5x7.6%8.2%1.274.6%+35.3%0.74%
AGARWALEYE
Dr. Agarwal's Health Care Limited
15,065 cr102.2x7.4x8.7%9.7%0.078.4%+26.0%0.01%
RAINBOW
Rainbow Childrens Medicare Limited
11,802 cr41.3x7.2x17.4%16.8%0.0015.9%+33.2%0.26%
PARKHOSPS
Park Medi World Limited
9,487 cr-4.7x-18.1%0.11--0.00%
YATHARTH
Yatharth Hospital & Trauma Care Services Limited
8,924 cr49.3x4.9x9.7%11.0%0.1413.1%+52.3%0.00%
HCG
Healthcare Global Enterprises Limited
8,508 cr367.6x6.4x2.4%6.9%0.651.3%+13.4%0.00%
ARTEMISMED
Artemis Medicare Services Limited
4,547 cr40.0x4.9x12.1%13.7%0.2410.2%+12.7%0.13%
INDRAMEDCO
Indraprastha Medical Corporation Limited
2,750 cr20.8x3.7x25.4%30.7%0.0012.3%+11.3%1.49%
JLHL
Jupiter Life Line Hospitals Limited
1,658 cr8.8x1.1x12.1%13.8%0.3312.0%+18.2%0.40%
GKSL
Gujarat Kidney And Super Speciality Limited
1,400 cr70.8x5.5x6.6%8.6%0.0616.6%-0.00%
SHALBY
Shalby Limited
1,240 cr32.9x1.2x3.7%7.9%0.543.2%+11.7%0.00%
GPTHEALTH
GPT Healthcare Limited
1,066 cr22.6x4.0x17.6%16.4%0.069.6%+17.8%1.92%
LOTUSEYE
Lotus Eye Hospital and Institute Limited
236 cr1419.5x3.9x0.2%1.1%0.190.3%+26.2%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
4 quarters
RevenueRs 34 Cr
Net profitRs 5 Cr
Sep 254 quarters filedJun 26

Each bar is one quarter as filed with the exchange, newest on the right, so the seasonal shape of the business is visible rather than smoothed away. Hover any quarter for its full figures and the change against the same quarter a year earlier. Revenue and profit are drawn on separate scales because they differ by an order of magnitude; reading one against the other would be misleading.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 8
DatePartySideQtyPriceValue
2026-10-26NEXUS GLOBAL OPPORTUNITIES FUNDSELL4,38,656178Rs 7.81 Cr
2026-10-07NATVARSINH T CHAVDASELL4,86,148192.19Rs 9.34 Cr
2026-10-07NATVARSINH T CHAVDABUY4,71,148188.97Rs 8.9 Cr
2026-10-05NATVARSINH T CHAVDASELL7,21,367192.11Rs 13.86 Cr
2026-10-05NATVARSINH T CHAVDABUY7,21,367189.1Rs 13.64 Cr
2026-10-05QE SECURITIES LLPBUY4,43,342192.61Rs 8.54 Cr
2026-10-05QE SECURITIES LLPSELL4,27,062190.48Rs 8.13 Cr
2026-10-01JUNOMONETA FINSOL PRIVATE LIMITEDBUY15,03,223198.86Rs 29.89 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 26 Oct
RSI (14) - momentum
47.6Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
71.7%Above average - stronger conviction
today 71.7%20d avg 37.2%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
+3.04%
vs 200-DMA
+34.10%
1-month
-0.08%
3-month
+38.51%
1-year
-
Realized vol (30d)
44.8%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on GKSL?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.